194 related articles for article (PubMed ID: 35832191)
1. High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.
Chen H; Zhao X; Li Y; Zhang S; Wang Y; Wang L; Ma W
Front Genet; 2022; 13():908807. PubMed ID: 35832191
[No Abstract] [Full Text] [Related]
2. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q
J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503
[No Abstract] [Full Text] [Related]
3. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
[No Abstract] [Full Text] [Related]
7. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
8. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J
Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242
[TBL] [Abstract][Full Text] [Related]
9. TMEM33 as a Prognostic Biomarker of Cervical Cancer and Its Correlation with Immune Infiltration.
Zhang H; Wang J; Yang J; He Q; Guan S; Qiao M; Zhao J; Wang X
Mediators Inflamm; 2023; 2023():5542181. PubMed ID: 37273452
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
12. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
[No Abstract] [Full Text] [Related]
13. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma.
Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ
Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.
Huang Y; Wu Q; Tan X
Bioengineered; 2022 Mar; 13(3):6955-6965. PubMed ID: 35249447
[TBL] [Abstract][Full Text] [Related]
15. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
Li G; Wang X; Liu G
Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
[TBL] [Abstract][Full Text] [Related]
16. RILPL2 is associated with the progression and prognosis of cervical squamous cell carcinoma and endocervical adenocarcinoma.
Dong Y; Wen W; Yuan T; Liu L; Li X
Am J Transl Res; 2023; 15(2):1072-1084. PubMed ID: 36915776
[TBL] [Abstract][Full Text] [Related]
17. Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma.
Liu J; Nie S; Li S; Meng H; Sun R; Yang J; Cheng W
Ann Transl Med; 2020 Jul; 8(14):868. PubMed ID: 32793712
[TBL] [Abstract][Full Text] [Related]
18. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
19. The sub-molecular characterization identification for cervical cancer.
Mo X; Wang N; He Z; Kang W; Wang L; Han X; Yang L
Heliyon; 2023 Jun; 9(6):e16873. PubMed ID: 37484385
[TBL] [Abstract][Full Text] [Related]
20. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
Lu X; Li R; Ying Y; Zhang W; Wang W
J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
